Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity

10 Mar 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Genetics, Aging, and Longevity in Model Organisms
Share to Medicinal Plants and Neuroprotection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24050239
DOI: 10.1016/j.ddtec.2012.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicityPMID 24050239Read ↗

Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeuticsSemantic proximity Read ↗

Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s diseaseSemantic proximity Read ↗

Understanding the molecular basis of Alzheimer’s disease using a Caenorhabditis elegans model systemSemantic proximity Read ↗

Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from Caenorhabditis elegans Transgenic ModelsSemantic proximity Read ↗

Modeling Alzheimer’s Disease in Caenorhabditis elegansSemantic proximity Read ↗

Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseasesSemantic proximity Read ↗

Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseasesSemantic proximity Read ↗

Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunitiesSemantic proximity Read ↗

Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson’s disease, Alzheimer’s disease and autism spectrum disorderSemantic proximity Read ↗

Caenorhabditis elegans as a model organism to study APP functionSemantic proximity Read ↗

Reserpine ameliorates Aβ toxicity in the Alzheimer’s disease model in Caenorhabditis elegansSemantic proximity Read ↗

Exploring Caenorhabditis elegans as Parkinson’s Disease Model: Neurotoxins and Genetic ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.